Company news
Endonovo Therapeutics, Inc. (OTC:ENDV) news
Endonovo Therapeutics, Inc. news releases on 6ix. Latest, Feb 20, 2020: Endonovo Therapeutics Begins Process For Medical Reimbursements
Press releases — page 2
Endonovo Therapeutics Begins Process For Medical Reimbursements
February 20, 2020
Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
February 13, 2020
Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries
February 10, 2020
Endonovo Therapeutics Reduces Debt
February 4, 2020
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
January 30, 2020
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
January 27, 2020
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis
January 14, 2020
Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke
January 7, 2020
Endonovo Therapeutics Provides SofPulse® To All NFL Teams [Updated]
December 23, 2019
Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock
December 19, 2019
Endonovo Therapeutics Announces Reverse Stock Split - UPDATE
December 11, 2019
Endonovo Therapeutics Announces Reverse Stock Split
December 11, 2019
Endonovo Therapeutics Reports Third Quarter 2019 Results
November 19, 2019
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
September 30, 2019
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
September 9, 2019
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
August 30, 2019
Endonovo Therapeutics Announces Second Quarter Results
August 13, 2019
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast
July 22, 2019
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board
July 15, 2019
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board
June 21, 2019
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
June 13, 2019
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire
May 29, 2019
Endonovo Therapeutics and Veterans Healthcare Supply Solutions Announce Distribution Agreement
May 21, 2019
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member
May 9, 2019
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing
May 7, 2019
Endonovo Therapeutics Hires David Clark as Vice President of Sales
May 3, 2019
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer
May 2, 2019
Endonovo Therapeutics Provides Corporate Update
April 26, 2019
Endonovo Therapeutics Announces Partnership with Second Hospital
March 29, 2019
Endonovo Therapeutics Partners with SunMED Medical Systems
March 20, 2019
Endonovo Therapeutics Announces New Website Launch
February 27, 2019
Endonovo Therapeutics Issues Shareholder Letter and Update
January 11, 2019
Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital
January 3, 2019
Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
December 18, 2018
Endonovo Expands SofPulse Commercialization
December 13, 2018
Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company
December 3, 2018
Endonovo Therapeutics Announces Complimentary New Product
November 8, 2018
Endonovo Therapeutics Provides Update on Liver Study
October 22, 2018
Endonovo Therapeutics Signs Distribution Agreement For National Distribution of Sofpulse® Electroceutical™ System
August 14, 2018
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
June 14, 2018
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®
May 9, 2018
Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
May 1, 2018
Endonovo Therapeutics Inc. to Move Forward with a Clinical Research Study Conducted by the Regents of the University of New Mexico
April 18, 2018
Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
February 12, 2018
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
February 1, 2018
Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema
January 22, 2018
Endonovo Therapeutics Provides Corporate Update and 2018 Outlook
January 16, 2018
Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
January 11, 2018
Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study
December 28, 2017
Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
December 26, 2017